Search
INFANT commits to support the implementation of the Global Strategy for Women’s, Children’s and Adolescents’ Health by continuing to progress our research and innovation in perinatal healthcare, thereby addressing the most common complications of pregnancy and most significant problems for newborn babies.

2015

INFANT (the Irish Centre for Fetal and Neonatal Translational Research) commits to support the implementation of the Global Strategy for Women’s, Children’s and Adolescents’ Health by continuing to progress our research and innovation in perinatal healthcare, thereby addressing the most common complications of pregnancy and most significant problems for newborn babies. INFANT recognizes that maternal and perinatal complications, which account for almost 10% of the global burden of disease, are disproportionately experienced in developing countries. INFANT will help to address this inequality through pioneering innovation in next generation devices that will transform antenatal and neonatal healthcare and service delivery.

INFANT is committed to translating our innovations into affordable, accessible and robust interventions (such as a chip-based screening test in early pregnancy for pre-eclampsia) that will reduce dependence on expensive technology and scarce human resources and expertise. This will have greatest impact in low resource settings where the burden of disease is highest. INFANT has made specific commitments for the next four years, including funding equipment for neonatal seizure detection and treatment in a low resource setting and will directly fund the doctoral research on pre-eclampsia of a low-income country researcher, thus promoting knowledge exchange and capacity building.